Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes
|
|
- Gerald Sims
- 5 years ago
- Views:
Transcription
1 Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Prof C. Wattal Hon. Sr. Consultant & Chairman Dept. of Clinical Microbiology Sir Ganga Ram Hospital New Delhi
2 AST to change outcomes Strike early and strike hard Golden first two hours of sepsis control
3
4
5 Essentials of a meaningful AST Speed, Reliability, Reproducibility & Follow up of AST in break through infections
6 Interpretation of susceptibility test results CLSI: publishes interpretive criteria for MICs of all relevant antibiotics for most bacterial genera (reviewed and updated every year) susceptible result: Patient s organism should respond to therapy with that antibiotic using the dosage recommended normally for that type of infection and species resistant result: Not inhibited by the concentrations of the antibiotic achieved with the dosages normally used with that drug intermediate result: microorganism falls into a range of susceptibility in which the MIC approaches or exceeds the level of antibiotic that can ordinarily be achieved and for which clinical response is likely to be less than with a susceptible strain CLSI M100-S24: Jan 2015; CID 2009;49:
7 Interpretive Criteria
8 % Resistance of Tigecycline - Blood Isolates - Ward & ICU E.coli Acinetobacter spp. Klebsiella spp. Shift from Disk Diffusion to MIC from 2010 onwards
9
10 Correlation between in vitro and in vivo situations: The Inoculum effect Refers to the decreasing efficacy of an antibiotic with increasing bacterial density Unique strategy of antibiotic tolerance Can complicate design of effective antibiotic treatment of bacterial infections Antibiotics that elicit the inoculum effect can lead to poor response to antibiotic treatment: The treatment efficacy drastically diminishes at ribosomal level of treatment Can cause overestimation of in vitro findings Increases generation of resistant pathogens
11 Case 1 A 40 year diabetic male developed fever & pain in right thigh since 1 week. On examination patient had fluctuant swelling over right thigh. Further excision drainage of the abscess was done and sent for microbiological examination. On Grams. Staining abundant gram positive cocci in pairs and bunches with many PMN cells were seen. On culture pure and heavy growth of Staph aureus was obtained which was subjected to AST. Blood culture also grew similar organism.
12 Antibiogram of Staphylococcus aureus Antimicrobial MIC Interpretation Remarks β lactamase NEG - Benzyl Penicillin < 0.12 S Oxacillin 0.5 S Erythromycin 0.5 S Clindamycin 0.25 S Trimethoprim sulfmethoxazole <2 S Ciprofloxacin <1 S Implications and Treatment options : Drug of choice : IV Penicillin/ Cloxacillin, Patients allergic to penicillin: Erythomycin or Clindamycin Erythromycin resistant and clindamycin sensitive- Ask for D-test All reported Vancomycin β lactamases negative methicillin 2 sensitive S S. aureus Report (MSSA) to be suppressed Vancomycin & Teicoplanin susceptibility report to be suppressed unless indicated MIC interpretation guideline : CLSI M100-S25 (2015)
13 Staphylococcus aureus clindamycin erythromycin oxacillin penicillin vancomycin S R R R S If clindamycin-s and erythromycin-r, do not report clindamycin-s without performance of D Test
14 D Test positive reaction Inducible clindamycin resistance (erm-mediated) mm another example Photos courtesy of J. Jorgensen and K. Fiebelko
15 Inducible Clindamycin Resistance - Incidence Varies considerably geographically Community-associated MRSA Frequently erythromycin-r clindamycin-s Often msra-mediated mechanism (NOT inducible) USA report % S. aureus erythromycin-r clindamycin-s 50% NOT inducible resistance Fiebelkorn et al JCM. 41:4740.
16 Antibiogram of Staphylococcus aureus Antimicrobial MIC Interpretation Antimicrobial Β lactamase POS + Cefoxitin screen POS + Benzyl Penicillin >= 0.5 R Oxacillin >=4 R Erythromycin >=8 R Clindamycin >4 R Ciprofloxacin >4 R Vancomycin 1 S MRSA resistant to all betalactam group of antibiotics including quinolones, aminoglycosides and macrolides irrespective of its in-vitro results. All reported Implications and treatment options Look for Vancomycin/ Teicoplanin susceptibility and manage Alternative drugs for management : Linezolid and Daptomycin MIC interpretation guideline : CLSI M100-S25 (2015)
17 What does CLSI Guidelines Say
18 THE MUTANT SELECTION WINDOW: Resistant Mutants are selected within a concentration Range (Mutant Prevention Concentration) The concentration range (MSW) extends from where the Inhibition begins approximated by the MIC up to the MPC Can be reduced : (Minimum Inhibitory Concentration) 1. Change in Antibiotic structure 2. Dosing Regimens 3. Combination Therapy Xilin Zhao et al. Restricting the Selection of Antibiotic-Resistan Mutants: A General Strategy Derived from Fluoroquinolone Studies Clinical Infectious Diseases 2001; 33(Suppl 3):S147 56
19 Vancomycin intermediate and resistant S. aureus When to consider h VISA? MRSA with vancomycin treatment failure Disc diffusion methods not reliable MIC testing to be done Rising Vancomycin MIC > 2 ug/ml while on treatment indicative h VISA
20 The Vanco Creep Sourced from. Gould IM, 2008, International Journal of antimicrobial Agents.
21 Case 2 A 15 year old adolescent was admitted with high grade continuous fever since five days. He also has cough with expectoration. Sputum and blood cultures were sent and both grew Streptococcus pneumoniae. The same was subjected to AST.
22 Antibiogram of Streptococcus pneumoniae Non meningitis isolates Antimicrobial Zone diameters (mm) MIC (ug/ml) Interpretation Penicillin x MIC test <2 S Cefotaxime recommended if <0.5 S Oxacillin zone <19mm Ceftriaxone <0.5 S Erythromycin 21 <0.25 S Clindamycin S Levofloxacin 17 <2 S Meropenem x <0.25 S Vancomycin and Linezolid 17 <1 S To be reported routinely for isolates other than from CSF Report to be suppressed routinely for penicillin susceptible isolates Reliable disk diffusion tests do not exist For nonmeningitis isolates Penicillin MIC of 0.06 ug/ml can predict susceptibility to (oral and parenteral) ampicillin, ampicillin-sulbactam, amoxicillin, amoxicillin-clavulanate, cephalosporins, and carbapenems In vitro susceptibility test to be performed using MIC method for penicillins, cephalosporins and carbapenems For penicillin resistant isolates Cefotaxime or ceftriaxone for penicillin non allergic Reserve drugs : Linezolid (so not reported routinely) Clinical Infectious Diseases 2001; 33(Suppl 3):S147 56
23 Antibiogram of Streptococcus pneumoniae For CSF isolates only Antimicrobial MIC Interpretation Penicillin >0.12 R Cefotaxime <0.5 S Ceftriaxone <0.5 S To be reported routinely for CSF isolates Meropenem <0.25 S Vancomycin No disc diffusion criteria for penicillin, cephalosporins and carbapenems MIC testing to be performed and only meningitis interpretations to be reported Susceptible ranges different from non meningitis isolates No FDA approved indication for use of cefepime for meningitis Drug choice for penicillin resistant isolates Ceftriaxone or cefotaxime Carbapenem Vancomycin for β lactam allergic <1 S Disk diffusion can be valid >17mm
24 Penicillin R in and around India India (< 1% R) Philipn. Thiland Malaysia Singapore Vietnam Srilanka 41.2 Pak 9 Indonesia 21 US 33 CID 2001;32(15 May): ; Tropical Med Int. Hlth.2005;10(3):
25 Case 3 A 26 year old male was admitted with continuous fever since three weeks. On examination patient was febrile, anemic had tachycardia and a left systolic murmur. On echocardiography mitral valve prolapse with large vegetation was seen. Patient was diagnosed as having bacterial endocarditis. Six blood cultures were drawn which grew Enterococcus faecium. AST for the same was done using Vitek system.
26 Antibiogram of Enterococcus faecium Antimicrobial Zone diameter (mm) Ampicillin <16 >=16 R Gentamicin High level (HLAR) 6 Growth present R Vancomycin <14 1 S Synergistic activity between ampicillin/ penicillin and an aminoglycoside can be predicted using high level aminoglycoside screening test Recommended routinely for bacterial endocarditis cases Not recommended on urinary isolates HLAR Resistant: not synergistic with cell wall active agent HLAR Susceptible: synergistic with cell wall active agent MIC (ug/ml) Interpretation Remarks For synergistic activity Linezolid <20 2 S Reserve drugs not Daptomycin Not reliable <4 S reported routinely Ampicillin resistant Vancomycin susceptible Enterococci MIC interpretation guideline : CLSI M100-S25 (2015)
27 Antibiogram of Enterococcus faecium Antimicrobial Zone diameter (mm) Ampicillin <16 >=16 R Gentamicin High level (HLAR) 6 Growth present R Vancomycin >17 >32 R E.gallinarum & E.casseliflavus : Intrinsic low level resistance to vancomycin Should not be treated with vancomycin Therapeutic options Linezolid Quinopristin-dalfopristin (E.faecium only) Others Daptomycin, fosfomycin, tigecycline MIC (ug/ml) Interpretation Remarks For synergistic activity Linezolid <20 2 S To be reported as Daptomycin Not reliable <4 S isolate is VRE Vancomycin resistant Enterococci MIC interpretation guideline : CLSI M100-S25 (2015) hvre: Organisms with intermediate zones be tested by MIC method
28 Enterococcus faecalis Ampicillin susceptibility can be used to predict imipenem susceptibility provided the species is confirmed to be E. faecalis. M100-S14 (M2, M7); Table 2D
29 Case 4 A 56 year old male after two weeks of having undergone liver transplant was admitted to the ICU with difficulty in breathing and fever. After admission patient s condition deteriorated and had to be intubated. After one week of intubation he developed VAP. His endotracheal secretions were sent for culture which grew Klebsiella pneumoniae. The same was subjected to AST.
30 Antibiogram of K.pneumoniae β lactamases Antimicrobial MIC Interpretation Antimicrobial MIC Interpretation Ampicillin >= 32 R Imipenem <= 0.25 S Amoxicillin Clavulanate <=2 S Amikacin <= 2 S Cefuroxime 2 S Gentamicin < = 1 S Ceftriaxone <= 1 S Ciprofloxacin < = 0.25 S Cefepime < = 1 S Preferable to avoid 3 rd and 4 th generation cephalosporins & carbapenems Report can be suppressed Trimethoprim/Sul famethoxazole Aztreonam <= 4 S Tigecycline Ertapenem <= 0.5 S Colistin < = 20 S Criteria not provided by CLSI EUCAST criteria followed CLSI criteria for Acinetobacter adopted β- lactamase postive: can be treated with B lactam- b lactam inhibitor combinations MIC interpretation guideline : CLSI M100-S25 (2015)
31 Antibiogram of K.pneumoniae ESBL Antimicrobial MIC Interpretation Antimicrobial MIC Interpretation Remarks Ampicillin >= 32 R Imipenem <= 0.25 S Amoxicillin Clavulanate <=2 S Amikacin <= 2 S Cefuroxime >= 32 R Gentamicin < = 1 S Ceftriaxone >=4 R Ciprofloxacin >1 R Cefepime <2 R Trimethoprim/Sulf amethoxazole Aztreonam >=16 R Tigecycline Ertapenem <= 0.5 S Colistin < = 20 S Criteria not provided by CLSI EUCAST criteria followed CLSI criteria for Acinetobacter adopted Report to be suppressed MIC interpretation guideline : CLSI M100-S25 (2015)
32 Extended spectrum B lactamases Treatment options Implications of ESBL production Antibiotic choice for infections with such organisms is reduced Plasmids bearing the genes encoding ESBLs frequently also carry genes encoding resistance to aminoglycosides, quinolones and trimethioprim/sulfamethoxazole Treatment options βlactam/β lactamase inhibitor combinations Carbapenems (including Imipenem, Meropenem, and Ertapenem) Cephamycins ESBL-producing organisms may lose outer membrane proteins leading to resistance to the cephamycins not related to β lactamase production
33 MIC interpretation guideline : CLSI M100-S25 (2015) Antibiogram of Klebsiella pneumoniae AmpC Antimicrobial MIC Interpretation Antimicrobial MIC Interpretation Ampicillin >= 32 R Amikacin <= 2 S Amoxicillin Clavulanate >= 32 R Gentamicin < = 1 S Cefuroxime >= 64 R Ciprofloxacin >1 S Ceftriaxone >= 64 R Tigecycline* <= 0.5 S Cefepime 2 S Colistin** < = 0.5 S Aztreonam 4 S Ertapenem <= 0.5 S Imipenem <= 0.25 S Resistant to β- lactam and β- lactam- inhibitor combinations, cephalosporins and sometimes carbapenems but spares cefepime Treatment options: Carbapenems Fluoroquinolone Tigecycline Trimethoprim/S ulfamethoxazole < = 20 S Piperacillin tazobactam >= 128 R * EUCAST criteria for tigecycline followed **Colistin breakpoints in CLSI for Acinetobacter adopted
34 Antibiogram of Klebsiella pneumoniae carbapenemases Antimicrobial MIC Interpretation Antimicrobial MIC Interpretation Ampicillin >= 32 R Amikacin <= 2 S Amoxicillin Clavulanate >= 32 R Gentamicin 8 I Cefuroxime >= 64 R Ciprofloxacin >1 R Ceftriaxone >= 64 R Tigecycline* <= 0.5 S Cefepime >=16 R Colistin** < = 0.5 S Aztreonam >= 16 R Trimethoprim/Sul famethoxazole >=4 R Ertapenem >=2 R Piperacillin tazobactam >= 128 R Imipenem >=4 R Organism resistant to therapy with carbepenems, regardless of in vitro status Treatment options Colistin Tigecyline Fosfomycin (Only for Urinary isolates) * EUCAST criteria for tigecycline followed **Colistin breakpoints in CLSI for Acinetobacter adopted MIC interpretation guideline : CLSI M100-S25 (2015)
35 H. influenzae Only results of testing with Ampicillin, 3 rd - generation cephalosporins and meropenem are appropriate to report routinely in CSF Amoxicillin-clavulanate, azithromycin, cefaclor, cefdinir, cefixime, cefpodoxime, cefuroxime, clarithromycin, are oral agents that may be used as empiric therapy for respiratory tract infections. The results of susceptibility tests with these antimicrobial agents are often not useful for management of individual patients.
36 A good predictor of antimicrobial efficacy Area under curve (AUC)/MIC ratio Concentration dependent & independent antibiotic concept Recognise the resistance potential particular antibiotic class Selective use of antibiotics Infectious Diseases Clinics of North America.:Aug 2003
37 Internationally Accepted guidelines to interpret AST for better outcomes
38 CLSI: Enterobacteriaceae Zones MM MIC For fosfomycin MIC determination, the medium must be supplemented with glucose-6-phosphate to a final concentration of 25 mg/l. Fosfomycin guidelines only for E.coli in urinary isolates
39 CLSI: Fosfomycin intrinsically resistant to A. baumannii and P. aeruginosa
40 CLSI: Enrerococci Zones MM MIC Guidelines available only for E. fecalis urinary isolates
41 EUCAST: Enterobacteriaceae MIC µgm Zones MM No zone sizes Fosfomycin guidelines not available for enteroocci and non-fermenters in EUCAST
42 Incompletely understood PK/PD. Tigecycline : blood isolates Daptomycin/ Linezolid: Urinary VRE Antibiotic not recommended for AST e.g Tigecycline : Urinary AND Pseudomonas
43 Understanding of Resistance can help interpret antibiogrammes
44 Case 5 A 60 year old female on 10 th day of her post renal transplant day developed low grade fever. She was was investigated and only blood culture was found to be positive for Candida non-albicans. The same was subjected to further identification and sensitivity.
45 Antibiogram of Candida non albicans C krusei Drug MIC Interpretation Remarks Fluconazole 32 R Intrinsically resistant Voriconazole <=0.12 S Amphotericin B* 0.5 S Caspofungin <=0.25 S *The CLSI breakpoints for Amphotericin B have not been defined In vitro studies in animal models have shown that if an amphotericin B MIC of >1ug/ml is obtained for a candida species isolate, then the isolate is likely to be resistant to amphotericin B CLSI document M27-S4 :2012
46 Antibiogram of Candida non albicans C galbrata Drug MIC Interpretation Remarks Fluconazole 2 S Voriconazole No guideline available Amphotericin B* 0.5 S Caspofungin <=0.25 S *The CLSI breakpoints for Amphotericin B have not been defined In vitro studies in animal models have shown that if an amphotericin B MIC of >1ug/ml is obtained for a candida species isolate, then the isolate is likely to be resistant to amphotericin B C. glabrata: Current data are insufficient to demonstrate a correlation between in vitro susceptibility testing and clinical outcome using voriconazole Susceptible criteria not provided by CLSI CLSI document M27-S4 :2012
47 Antifungal Sensitivity interpretation guidelines Difficult organisms C.haemulonii and C.auris No guidelines by CLSI Studies extrapolate interpretative criteria of C.albicans for these isolates Drug MIC Interpretation Remarks Fluconazole 32 I Shows variable susceptibility pattern Voriconazole <=0.12 S Amphotericin B 8 R MIC usually raised Caspofungin 0.5 S
48 Thanks
European Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationMechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
More informationStreptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationChallenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems
Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More information2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital
2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....
More information2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital
2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationAvailable online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
More informationAberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015
Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More information21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationTable 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.
Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance
More informationENTEROCOCCI. April Abbott Deaconess Health System Evansville, IN
ENTEROCOCCI April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic antimicrobial susceptibility principles and resistance mechanisms for Enterococcus Describe issues surrounding AST
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
More information56 Clinical and Laboratory Standards Institute. All rights reserved.
Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:
More informationPrinciples of Antimicrobial Therapy
Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1
More informationINFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER
INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are
More informationAntimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More information2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationEinheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?
Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Andrea Duppenthaler andrea.duppenthaler@insel.ch Limping patient local pain swelling tenderness warmth fever acute Osteomyelitis
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationAntimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013
Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases
More informationEducating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges
Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Janet Hindler, MCLS MT(ASCP) UCLA Medical Center jhindler@ucla.edu also working as a consultant with the Association
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationDr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College
Dr. Shaiful Azam Sazzad MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College INTRODUCTION ICU acquired infection account for substantial morbidity, mortality and expense. Infection and
More informationSimilar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.
Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds
More informationUpdate on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital
Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia Po-Ren Hsueh National Taiwan University Hospital Ventilator-associated Pneumonia Microbiological Report Sputum from a
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationESCMID Online Lecture Library. by author
Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationPenicillins - EUCAST clinical MIC breakpoints (version 1.3)
EUCAST clinical MIC breakpoints - penicillins Penicillins - EUCAST clinical MIC breakpoints 2009-04-19 (version 1.3) Penicillins Click on antibiotic name to see wild type MIC distributions. Enterobacteriaceae
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationAntimicrobial Therapy
Antimicrobial Therapy David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Disclosure: Dr. Spach has no significant financial interest in any of the
More informationAntimicrobial Resistance Strains
Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant
More informationBritish Society for Antimicrobial Chemotherapy
British Society for Antimicrobial Chemotherapy Standing Committee on Susceptibility Testing Version 13.0, 10-06-2014 Content Page Additional information Changes in version 13 2 Suggestions for appropriate
More informationBritish Society for Antimicrobial Chemotherapy
British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More information5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)
Multidrug Resistant Organisms (MDROs) Kasturi Shrestha, M.D. 05/11/2018 Objectives Define a multi-drug resistant organism (MDRO) Identify most challenging MDROs in healthcare Identify reasons for health
More informationTaiwan Surveillance of Antimicrobial Resistance (TSAR)
Taiwan Surveillance of Antimicrobial Resistance (TSAR) 2009 MIRL Symposium July 17, 2009 Tsai-Ling Yang Lauderdale ( ) Microbial Infections Reference Laboratory (MIRL) Division of Infectious Diseases,
More informationBACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)
BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016) VA Palo Alto Health Care System April 14, 2017 Trisha Nakasone, PharmD, Pharmacy Service Russell Ryono, PharmD, Public Health Surveillance
More informationBacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching
More informationEUCAST-and CLSI potency NEO-SENSITABS
EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationNew Drugs for Bad Bugs- Statewide Antibiogram
New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationPerformance Information. Vet use only
Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.
More informationANTIMICROBIAL RESISTANCE SURVEILLANCE FROM SENTINEL PUBLIC HOSPITALS, SOUTH AFRICA, 2014
ANTIMICROBIAL RESISTANCE SURVEILLANCE FROM SENTINEL PUBLIC HOSPITALS, SOUTH AFRICA, 2014 Olga Perovic, 1,2 Verushka Chetty 1 & Samantha Iyaloo 1 1 National Institute for Communicable Diseases, NHLS 2 Department
More informationIntroduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More information2015 Antimicrobial Susceptibility Report
Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf
More informationManagement of Native Valve
Management of Native Valve Infective Endocarditis 2005 AHA 2015 Baddour LM, et al. Circulation. 2015;132(15):1435-86 2009 ESC 2015 Habib G, et al. Eur Heart J. 2015;36(44):3075-128 ESC 2015: Endocarditis
More informationWhat s next in the antibiotic pipeline?
What s next in the antibiotic pipeline? Jennifer Tieu, Pharm.D., BCPS Clinical Pearls OSHP Spring Meeting Mercy Hospital April 13, 2018 Objective 2 Describe the drug class and mechanism of action of antibiotics
More informationAntimicrobial Resistance Trends in the Province of British Columbia
655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel 604.707.2443 Fax 604.707.2441 www.bccdc.ca Antimicrobial Resistance Trends in the Province of British Columbia 2013 Prepared by the Do Bugs Need Drugs? Program
More informationANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin
ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria
More informationInfectious Disease: Drug Resistance Pattern in New Mexico
Infectious Disease: Drug Resistance Pattern in New Mexico Are these the world's sexiest accents? Obi C. Okoli, MD.,MPH. Clinic for Infectious Diseases Las Cruces, NM. Are these the world's sexiest accents?
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationManagement of Hospital-acquired Pneumonia
Management of Hospital-acquired Pneumonia Adel Alothman, MB, FRCPC, FACP Asst. Professor, COM, KSAU-HS Head, Infectious Diseases, Department of Medicine King Abdulaziz Medical City Riyadh Saudi Arabia
More informationWhat is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown
What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups Gunnar Kahlmeter, Derek Brown Izmir, February 2011 Anaerobes subcommittee EUCAST Subcommittee on breakpoints
More information